Healthcare

Insilico Medicine showcases generative AI drug discovery and laboratory automation

Insilico Medicine is highlighting a generative-AI and robotics platform for drug discovery at events including Dubai Future Week.

Insilico Medicine announced that its leadership would present work on AI-driven therapeutics and laboratory automation at international investor and technology gatherings in London and Dubai. The company’s Dubai Future Week presentation is scheduled to focus on generative AI and laboratory automation for drug discovery and longevity. Insilico describes a closed-loop model combining proprietary generative-AI algorithms with automated robotic laboratories. The approach is intended to support target identification, candidate optimization, and therapeutic-pipeline development. The Dubai event, hosted by Dubai Future Foundation, is scheduled for 18 to 21 November 2026 and is expected to bring together technology, policy, and research participants. The source reports a planned presentation rather than a newly launched clinical product.

Original source: ScienMag

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI